CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

agalsidase betaPositive
AI Analysis

Summary

Biosidus announced that its new bioreactor plant is now operational, expanding manufacturing capacity and global supply capabilities for agalsidase beta biosimilar.

Importance:3/10
Sentiment:
0.60
manufacturingcapacity expansionbiosimilarbioreactor
Related Companies

Read the original article

Published by PR Newswire Pharma on August 26, 2026 9:00 PM

Read Original